What is the recommended initial dose of noradrenaline (norepinephrine) for treating shock, specifically septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Dosing for Shock

The recommended initial dose of norepinephrine for treating shock is 0.1-0.5 mcg/kg/min (7-35 mcg/min in a 70-kg adult), with titration to maintain a target mean arterial pressure (MAP) of 65 mmHg. 1

Initial Dosing and Administration

  • According to the American College of Critical Care Medicine and the Society of Critical Care Medicine, the initial dose of norepinephrine should be 0.1-0.5 mcg/kg/min 1
  • The FDA label recommends starting with 8-12 mcg/min (0.25-0.375 mL/min of standard concentration) and adjusting to maintain blood pressure (usually 80-100 mmHg systolic) 2
  • Administration should be through a central venous line whenever possible to avoid tissue necrosis from extravasation 1
  • An arterial catheter should be placed for continuous blood pressure monitoring 1

Titration and Maintenance

  • Titrate by 0.05-0.1 μg/kg/min every 5-15 minutes to achieve target MAP 1
  • The average maintenance dose ranges from 2-4 mcg/min (0.0625-0.125 mL/min) according to the FDA label 2
  • Target MAP should be 65 mmHg for most patients, but may need to be higher (75-85 mmHg) in patients with chronic hypertension 1, 3

Timing of Initiation

  • Early administration of norepinephrine is beneficial in septic shock 4, 5
  • The CENSER trial demonstrated that early norepinephrine administration (at 0.05 μg/kg/min) was associated with better shock control by 6 hours (76.1% vs 48.4%) compared to standard treatment 5
  • Early norepinephrine administration may reduce fluid requirements and improve outcomes 4, 5

Monitoring and Precautions

  • Monitor for:

    • Tissue perfusion markers (lactate clearance, urine output, skin perfusion, mental status)
    • Renal and liver function
    • Cardiac function, especially in patients with underlying heart disease (risk of arrhythmias)
    • Signs of extravasation 1
  • Ensure adequate fluid resuscitation before and during norepinephrine administration, as it is relatively contraindicated in hypovolemia 1

  • Use cautiously in patients with ischemic heart disease as it may increase myocardial oxygen requirements 1

Special Considerations

  • If extravasation occurs, infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline into the site to prevent tissue necrosis 1
  • Norepinephrine has been shown to be superior to other vasopressors in minimizing the occurrence of arrhythmias 6
  • For refractory shock, consider adding vasopressin (0.01-0.04 U/min) rather than continuing to escalate norepinephrine doses 1, 3

Common Pitfalls to Avoid

  • Delaying norepinephrine initiation in profound shock (e.g., diastolic BP ≤ 40 mmHg) while waiting for fluid resuscitation to be completed 4
  • Using peripheral IV access for prolonged norepinephrine administration (increases risk of extravasation)
  • Abrupt discontinuation (can cause marked hypotension) - reduce infusion rate gradually 2
  • Failure to monitor for and address underlying causes of shock while administering vasopressors 1

References

Guideline

Management of Refractory Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Research

Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.

American journal of respiratory and critical care medicine, 2019

Research

Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.

The western journal of emergency medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.